Haiyang Luo

979 total citations
45 papers, 654 citations indexed

About

Haiyang Luo is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Haiyang Luo has authored 45 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 20 papers in Molecular Biology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Haiyang Luo's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Genetic Neurodegenerative Diseases (8 papers) and Neurological diseases and metabolism (7 papers). Haiyang Luo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Genetic Neurodegenerative Diseases (8 papers) and Neurological diseases and metabolism (7 papers). Haiyang Luo collaborates with scholars based in China, United States and Bulgaria. Haiyang Luo's co-authors include Mibo Tang, Shuo Zhang, Yu-ming Xu, Chang-he Shi, Yuming Xu, Changhe Shi, Chengyuan Mao, Liyuan Fan, Jing Yang and Zhengwei Hu and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Haiyang Luo

43 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiyang Luo China	15	326	192	116	108	99	45	654
Hisae Sumi Japan	11	311 1.0×	289 1.5×	142 1.2×	159 1.5×	106 1.1×	15	707
Elisabeth Barski Germany	9	277 0.8×	143 0.7×	254 2.2×	117 1.1×	107 1.1×	9	640
Loredana Spoerri Australia	11	293 0.9×	118 0.6×	115 1.0×	110 1.0×	248 2.5×	13	717
Hsueh‐Ning Liu Canada	15	420 1.3×	234 1.2×	207 1.8×	159 1.5×	85 0.9×	16	891
William Hill United Kingdom	12	250 0.8×	237 1.2×	228 2.0×	120 1.1×	170 1.7×	15	831
Toni Ahtoniemi Finland	9	191 0.6×	128 0.7×	91 0.8×	101 0.9×	194 2.0×	11	473
Brian C. Kramer United States	16	199 0.6×	163 0.8×	218 1.9×	125 1.2×	53 0.5×	26	670
Charlotte Veyrat‐Durebex France	17	385 1.2×	366 1.9×	70 0.6×	113 1.0×	164 1.7×	42	801
Huan Xiong China	11	448 1.4×	141 0.7×	140 1.2×	147 1.4×	100 1.0×	15	1.1k
Eulalia Rodrı́guez-Martı́n Spain	14	207 0.6×	112 0.6×	144 1.2×	104 1.0×	102 1.0×	37	604

Countries citing papers authored by Haiyang Luo

Since Specialization

Citations

This map shows the geographic impact of Haiyang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyang Luo more than expected).

Fields of papers citing papers by Haiyang Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyang Luo. The network helps show where Haiyang Luo may publish in the future.

Co-authorship network of co-authors of Haiyang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyang Luo. A scholar is included among the top collaborators of Haiyang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyang Luo. Haiyang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Fei, Haiyang Luo, Xiao Wang, et al.. (2025). Application of Anti‐Motion Ultra‐Fast Quantitative MRI in Neurological Disorder Imaging: Insights From Huntington's Disease. Journal of Magnetic Resonance Imaging. 61(6). 2455–2468.

Tang, Mibo, Yixuan Liu, Zhengwei Hu, et al.. (2025). Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential. Frontiers in Aging Neuroscience. 16. 1454735–1454735. 3 indexed citations

Luo, Haiyang, et al.. (2025). Prediction of Lithium Mineralization Potential in the Jiulong Area, Western Sichuan (China), Using Spectral Residual Attention Convolutional Neural Network. Natural Resources Research. 34(3). 1331–1350. 2 indexed citations

Zhang, Yi, Yong Zhang, Jinyi Li, et al.. (2024). Wall permeability on magnetic resonance imaging is associated with intracranial aneurysm symptoms and wall enhancement. European Radiology. 34(8). 5204–5214. 1 indexed citations

Wang, Yunchao, Haiyang Luo, Bo Song, et al.. (2024). Novel inflammatory and insulin resistance indices provide a clue in cerebral amyloid angiopathy. Scientific Reports. 14(1). 11474–11474. 2 indexed citations

Li, Jiaqi, Jing Yang, Yanpeng Yuan, et al.. (2024). Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson’s disease in the Chinese population. European journal of medical research. 29(1). 114–114. 7 indexed citations

Li, Jiaqi, et al.. (2023). Independent episodes of vestibular paroxysmia and hemifacial spasm duo to a distorted vertebral artery in one patient. Acta Neurologica Belgica. 124(5). 1679–1681. 1 indexed citations

Yang, Jing, Jiaqi Li, Yanpeng Yuan, et al.. (2023). Seed amplification assay of nasal swab extracts for accurate and non-invasive molecular diagnosis of neurodegenerative diseases. Translational Neurodegeneration. 12(1). 13–13. 4 indexed citations

Shi, Changhe, Tai Wang, Jing Yang, et al.. (2022). Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease. Journal of Neurology. 269(12). 6386–6394. 20 indexed citations

10.

Hu, Xinchao, Chengyuan Mao, Liyuan Fan, et al.. (2020). Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells. Stem Cells International. 2020. 1–15. 24 indexed citations

11.

Luo, Haiyang, Chengyuan Mao, Zhi-hua Yang, et al.. (2019). Novel compound heterozygous GFPT1 mutations in a family with limb-girdle myasthenia with tubular aggregates. Neuromuscular Disorders. 29(7). 549–553. 7 indexed citations

12.

Zhang, Shuo, Zhengwei Hu, Haiyang Luo, et al.. (2019). AAV/BBB-Mediated Gene Transfer of CHIP Attenuates Brain Injury Following Experimental Intracerebral Hemorrhage. Translational Stroke Research. 11(2). 296–309. 35 indexed citations

13.

Mao, Chengyuan, Herui Wang, Haiyang Luo, et al.. (2018). CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I. Neurobiology of Aging. 75. 38–41. 18 indexed citations

14.

Tang, Mibo, Shuo Zhang, Haiyang Luo, et al.. (2018). Anisomycin prevents OGD-induced necroptosis by regulating the E3 ligase CHIP. Scientific Reports. 8(1). 6379–6379. 19 indexed citations

15.

Luo, Haiyang, et al.. (2017). Arginine vasopressin relates with spatial learning and memory in a mouse model of spinocerebellar ataxia type 3. Neuropeptides. 65. 83–89. 5 indexed citations

16.

Mao, Chengyuan, Jing Yang, Hui Wang, et al.. (2016). SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease. Parkinsonism & Related Disorders. 34. 59–61. 25 indexed citations

17.

Shi, Changhe, Hui Wang, Chengyuan Mao, et al.. (2016). MC1R variants in Chinese Han patients with sporadic Parkinson's disease. Neurobiology of Aging. 42. 217.e5–217.e6. 4 indexed citations

18.

Shi, Changhe, Dandan Shang, Shilei Sun, et al.. (2015). MMACHC gene mutation in familial hypogonadism with neurological symptoms. Gene. 574(2). 380–384. 3 indexed citations

19.

Luo, Haiyang, Changhe Shi, Chengyuan Mao, et al.. (2015). A novel compound WISP3 mutation in a Chinese family with progressive pseudorheumatoid dysplasia. Gene. 564(1). 35–38. 15 indexed citations

20.

Li, Yusheng, Chengyuan Mao, Changhe Shi, et al.. (2015). Exome sequencing reveals novel SPG11 mutation in hereditary spastic paraplegia with complicated phenotypes. Journal of Clinical Neuroscience. 22(7). 1150–1154. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact